GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Change In Other Working Capital

ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Change In Other Working Capital : $0.00 Mil (TTM As of Jun. 2020)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition II Change In Other Working Capital?

ARYA Sciences Acquisition II's Change In Other Working Capital for the quarter that ended in Jun. 2020 was $0.00 Mil. It means ARYA Sciences Acquisition II's Other Working Capital stayed the same from Mar. 2020 to Jun. 2020 .

ARYA Sciences Acquisition II's Change In Other Working Capital for the fiscal year that ended in . 20 was $0.00 Mil. It means ARYA Sciences Acquisition II's Other Working Capital stayed the same from . 20 to . 20 .

ARYA Sciences Acquisition II Change In Other Working Capital Historical Data

The historical data trend for ARYA Sciences Acquisition II's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARYA Sciences Acquisition II Change In Other Working Capital Chart

ARYA Sciences Acquisition II Annual Data
Trend
Change In Other Working Capital

ARYA Sciences Acquisition II Semi-Annual Data
Feb20 Mar20 Jun20
Change In Other Working Capital - - -

ARYA Sciences Acquisition II Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2020 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYA Sciences Acquisition II Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition II's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Change In Other Working Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp II is a blank check company.
Executives
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc director 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Life Sciences Master Fund Ltd director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Adam Leo Stone director, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Ii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Jake Bauer director C/O MYOKARDIA, INC., 333 ALLERTON AVENUE, SOUTH SAN FRANCISCO CA 94080
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016
Chad M Robins director C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102